Expedite Market Access with cutting edge value frameworks
Feb 29, 2024
With payer expectations changing more so than ever before, pharma must create compelling evidence plans to fast-track their place in the market
Hear from AstraZeneca, Sanofi, Takeda and Novartis about:
- Tailor your products value proposition by having early conversations with committees, advocacy groups and ad boards.
- Craft a robust evidence plan that will expedite product launch enabling a competitive edge in the market.
- Harness patient-focused real world data that will strengthen payer value and accelerate access to medication.
- More than drugmakers: Open new channels of business by creating new concepts of value, such as indicating health equity as a criteria.